Medication Summary
The goals of pharmacotherapy are to reduce morbidity and to prevent complications. Corticosteroids might be indicated in patients with refractory celiac sprue.
Corticosteroids
Class Summary
Corticosteroids have anti-inflammatory properties and cause profound and varied metabolic effects. These agents modify the body's immune response to diverse stimuli.
Prednisone (Deltasone, Orasone, Sterapred)
Can be used in patients with refractory celiac sprue. Might decrease inflammation by reversing increased capillary permeability and suppressing PMN activity.
Green PH, Cellier C. Celiac disease. N Engl J Med. Oct 25 2007;357(17):1731-43. [Medline].
Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest. Jan 2007;117(1):41-9. [Medline].
Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. Jul 2009;137(1):88-93. [Medline].
Yachha SK, Misra S, Malik AK, Nagi B, Mehta S. Spectrum of malabsorption syndrome in north Indian children. Indian J Gastroenterol. Oct 1993;12(4):120-5. [Medline].
Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol. Aug 2009;24(8):1347-51. [Medline].
Rashtak S, Murray JA. Celiac disease in the elderly. Gastroenterol Clin North Am. Sep 2009;38(3):433-46. [Medline].
Ludvigsson JF, Zingone F, Tomson T, Ekbom A, Ciacci C. Increased risk of epilepsy in biopsy-verified celiac disease: A population-based cohort study. Neurology. May 1 2012;78(18):1401-7. [Medline].
Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol. Mar 2003;36(3):219-21. [Medline].
Errichiello S, Esposito O, Di Mase R, Camarca ME, Natale C, Limongelli MG, et al. Celiac Disease: Predictors of Compliance With a Gluten-free Diet in Adolescents and Young Adults. J Pediatr Gastroenterol Nutr. Jul 28 2009;[Medline].
Mollazadegan K, Kugelberg M, Lindblad BE, Ludvigsson JF. Increased risk of cataract among 28,000 patients with celiac disease. Am J Epidemiol. Jul 15 2011;174(2):195-202. [Medline].
Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. Nov 2002;123(5):1428-35. [Medline].
Catassi C, Rätsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F. Coeliac disease in the year 2000: exploring the iceberg. Lancet. Jan 22 1994;343(8891):200-3. [Medline].
Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. Jan 2005;17(1):85-91. [Medline].
Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. Jul 1997;3(7):797-801. [Medline].
Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. Jan 17 2002;346(3):180-8. [Medline].
Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. Feb 10 2003;163(3):286-92. [Medline].
Ferguson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease--active, silent, latent, potential. Gut. Feb 1993;34(2):150-1. [Medline].
Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterology. Jul 1998;115(1):206-10. [Medline].
Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut. May 2002;50(5):624-8. [Medline].
Green PH, Jabri B. Coeliac disease. Lancet. Aug 2 2003;362(9381):383-91. [Medline].
James MW, Scott BB. Coeliac disease: the cause of the various associated disorders?. Eur J Gastroenterol Hepatol. Sep 2001;13(9):1119-21. [Medline].
Johnson TC, Diamond B, Memeo L, et al. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol. Oct 2004;2(10):888-94. [Medline].
Mention JJ, Ben Ahmed M, Begue B, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. Sep 2003;125(3):730-45. [Medline].
Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol. Jan 2003;1(1):19-27. [Medline].
Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol. Jan 2003;1(1):19-27. [Medline].
Pietzak MM, Schofield TC, McGinniss MJ, Nakamura RM. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gastroenterol Hepatol. Sep 2009;7(9):966-71. [Medline].
Rashtak S, Murray JA. Celiac disease in the elderly. Gastroenterol Clin North Am. Sep 2009;38(3):433-46. [Medline].
Rostami K, Malekzadeh R, Shahbazkhani B, et al. Coeliac disease in Middle Eastern countries: a challenge for the evolutionary history of this complex disorder?. Dig Liver Dis. Oct 2004;36(10):694-7. [Medline].
Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. Dec 2006;131(6):1981-2002. [Medline].
Salmi TT, Collin P, Korponay-Szabo IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. Dec 2006;55(12):1746-53. [Medline].
Sanders DS, Hurlstone DP, McAlindon ME, et al. Antibody negative coeliac disease presenting in elderly people--an easily missed diagnosis. BMJ. Apr 2 2005;330(7494):775-6. [Medline].
Sategna-Guidetti C, Pulitanó R, Grosso S, et al. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol. Sep 1993;17(2):123-7. [Medline].
Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut. Jan 2005;54(1):54-9. [Medline].

